What You Should Know
Axoft has raised an oversubscribed $55M Series A led by C.P. Group Innovation, bringing its total funding to over $60M.The capital will be used to expand global clinical trials, progress U.S. regulatory approval for its implantable Brain-Computer Interfaces (iBCIs), and build a GMP manufacturing facility in Cambridge, MA.Axoft’s iBCIs utilize a proprietary material called Fleuron™, which is 10,000x softer than traditional polyimide, significantly reducing tissue scarring
Read More
AiZtech Labs Launches iSelfie BioSignals in U.S. to Automate Intake and Digital Biomarker Detection
What You Should Know
AiZtech Labs has officially launched iSelfie BioSignals in the U.S., a smartphone-based platform that detects digital biomarkers using a standard selfie-camera interaction.The platform is designed to generate clinically meaningful measurements from the eye and surrounding skin, helping care teams prioritize patients faster and reduce reliance on device-heavy hardware.Clinical validation includes data from over 5,000 human participants across six studies in the U.S.,
Read More
Viz.ai and NRHA Collaborate to Deploy AI in Rural Hospitals
What You Should Know
Viz.ai has partnered with the National Rural Health Association (NRHA) through its Rural Hospital & Clinic Partnership Program to help rural leaders implement AI-powered detection and coordination tools.The initiative targets a significant "adoption gap": rural hospitals are currently 25% less likely to adopt new technologies like AI than urban facilities due to funding and geographic barriers.The Viz platform analyzes medical images and clinical data in real time to
Read More
Greatly Health Secures $4M to Scale MSK-Validated Integrative Oncology Platform
What You Should Know
Greatly Health raised a $4 million seed round co-led by Pear VC and Commonweal Ventures to bring integrative oncology to a broader patient population.The company's virtual model was originally developed and validated at Memorial Sloan Kettering Cancer Center (MSK).In clinical trials, the program demonstrated a 16% absolute improvement in overall survival at two years and a 69% reduction in hospitalizations.The platform provides live, expert-led group sessions in exercise,
Read More
Nordic 2026 Survey: Epic Managed Services Transition from Staffing Support to Strategic IT Operating Model
What You Should Know
Nordic Global has released 2026 survey findings showing that 61% of healthcare IT leaders now view Application Managed Services (AMS) as a central, rather than supplemental, part of their IT strategy.The market is seeing a distinct urban-rural divide: 70% of urban organizations view AMS as a strategic lever for transformation, compared to 43% of rural organizations who use it primarily for operational resilience.Urban and large health systems are increasingly using AMS to
Read More
Aidoc Secures $150M to Accelerate Enterprise-Scale Clinical AI Across 2,000 Hospitals
What You Should Know
Aidoc has raised $150M in Series E funding, led by Growth Equity at Goldman Sachs Alternatives, bringing its total funding to over $500M. The round included participation from General Catalyst, SoftBank Investment Advisors, and NVentures (NVIDIA's venture capital arm).Capital will be used to further develop Aidoc's CARE™ clinical foundation model and its aiOS™ enterprise platform.The company currently analyzes more than 60 million patient cases annually and is deployed
Read More
Operationalizing Precision Medicine 2026: U.S. Health Systems Scale Genetic Testing and AI Integration
What You Should Know
Precision medicine has transitioned from "one-off" testing to organized institutional programs at more than three-quarters of surveyed U.S. health systems, according to new research from the Center for Connected Medicine (CCM) at UPMC.This represents a massive shift from 2020, when 69% of organizations had little to no precision medicine deployment.While adoption is high, reimbursement uncertainty, high costs, and operational complexity remain the primary barriers to
Read More
CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring
What You Should Know
CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cancers.The deal includes $160M in up-front cash, with potential for an additional $100M based on future revenue milestones.Naveris’ flagship platform utilizes Tumor Tissue Modified Viral (TTMV®) DNA to detect and monitor HPV-driven cancers with high accuracy.The acquisition is expected to close in the third quarter of
Read More
Rad AI Appoints David Leonard as COO and Elizabeth Bergey, MD, as First Chief Clinical Officer
What You Should Know
Rad AI has appointed David Leonard as Chief Operating Officer (COO) and Elizabeth Bergey, MD, as the company’s first Chief Clinical Officer (CCO).Leonard, previously Head of Operations, Strategy, and Investor Relations, will focus on scaling internal infrastructure and enhancing go-to-market strategies for AI-enabled reporting.Dr. Bergey, a board-certified radiologist and former CEO of Quantum Radiology, transitions from Chief Medical Innovation Officer to lead clinical
Read More
Weave Bio Launches AI-Native NDA Submission Support in Strategic Partnership with Parexel
What You Should Know
Weave Bio has expanded its AI-native regulatory platform to support New Drug Application (NDA) submissions, covering the full drug development lifecycle.Strategic partner Parexel co-developed and refined the platform, resulting in authoring speeds that are 60% faster than traditional manual methods.The platform utilizes AI-native data extraction, content verification, and automated authoring to synthesize clinical, non-clinical, and manufacturing data.Parexel will
Read More
